5u3r
From Proteopedia
(Difference between revisions)
(One intermediate revision not shown.) | |||
Line 1: | Line 1: | ||
==Human PPARdelta ligand-binding domain in complexed with specific agonist 2== | ==Human PPARdelta ligand-binding domain in complexed with specific agonist 2== | ||
- | <StructureSection load='5u3r' size='340' side='right' caption='[[5u3r]], [[Resolution|resolution]] 1.95Å' scene=''> | + | <StructureSection load='5u3r' size='340' side='right'caption='[[5u3r]], [[Resolution|resolution]] 1.95Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[5u3r]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5U3R OCA]. For a <b>guided tour on the structure components</b> use [ | + | <table><tr><td colspan='2'>[[5u3r]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5U3R OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5U3R FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=7V1:6-[2-({[4-(FURAN-2-YL)BENZENE-1-CARBONYL](PROPAN-2-YL)AMINO}METHYL)PHENOXY]HEXANOIC+ACID'>7V1</scene>, <scene name='pdbligand=B7G:HEPTYL-BETA-D-GLUCOPYRANOSIDE'>B7G</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene>, <scene name='pdbligand=PGO:S-1,2-PROPANEDIOL'>PGO</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.95Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=7V1:6-[2-({[4-(FURAN-2-YL)BENZENE-1-CARBONYL](PROPAN-2-YL)AMINO}METHYL)PHENOXY]HEXANOIC+ACID'>7V1</scene>, <scene name='pdbligand=B7G:HEPTYL-BETA-D-GLUCOPYRANOSIDE'>B7G</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene>, <scene name='pdbligand=PGO:S-1,2-PROPANEDIOL'>PGO</scene></td></tr> | |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5u3r FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5u3r OCA], [https://pdbe.org/5u3r PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5u3r RCSB], [https://www.ebi.ac.uk/pdbsum/5u3r PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5u3r ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/PPARD_HUMAN PPARD_HUMAN] Ligand-activated transcription factor. Receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Has a preference for poly-unsaturated fatty acids, such as gamma-linoleic acid and eicosapentanoic acid. Once activated by a ligand, the receptor binds to promoter elements of target genes. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as transcription activator for the acyl-CoA oxidase gene. Decreases expression of NPC1L1 once activated by a ligand.<ref>PMID:1333051</ref> <ref>PMID:15604518</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 19: | Line 19: | ||
</div> | </div> | ||
<div class="pdbe-citations 5u3r" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5u3r" style="background-color:#fffaf0;"></div> | ||
+ | |||
+ | ==See Also== | ||
+ | *[[Peroxisome proliferator-activated receptor 3D structures|Peroxisome proliferator-activated receptor 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: | + | [[Category: Atkins AR]] |
- | [[Category: | + | [[Category: Baiga TJ]] |
- | [[Category: | + | [[Category: Bowman ME]] |
- | [[Category: | + | [[Category: Downes M]] |
- | [[Category: | + | [[Category: Evans RM]] |
- | [[Category: | + | [[Category: La Clair JJ]] |
- | [[Category: | + | [[Category: Noel JP]] |
- | [[Category: | + | [[Category: Richard SB]] |
- | [[Category: | + | [[Category: Stockley-Noel TA]] |
- | + | [[Category: Wu C-C]] | |
- | [[Category: | + | |
- | + |
Current revision
Human PPARdelta ligand-binding domain in complexed with specific agonist 2
|
Categories: Homo sapiens | Large Structures | Atkins AR | Baiga TJ | Bowman ME | Downes M | Evans RM | La Clair JJ | Noel JP | Richard SB | Stockley-Noel TA | Wu C-C